Asthma Insights: Treating by Phenotype and Improving Adherence to Treatment

1.25 CME
1.25 ABIM MOC
75 MINS
$0 FEE
SAVE
Asthma Insights: Treating by Phenotype and Improving Adherence to Treatment

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This educational activity is supported by an educational grant from GlaxoSmithKline.


Activity Description

Asthma is poorly controlled in up to 50% of patients. This is often due to failure to avoid triggers, inadequate use of anti-inflammatory medications, as well as inconsistencies between patients’ perceptions of control and actual symptoms. However, increasing evidence suggests that an estimated 5% to 10% of patients have severe asthma subtypes for which standard therapy is ineffective. Guidelines from the European Respiratory Society and American Thoracic Society propose that certain characteristics, such as eosinophilic airway inflammation, could be used to guide health care professionals in tailoring an individualized treatment approach for severe asthma phenotypes. In this recorded symposium, experts discuss asthma phenotypes and their implications for treatment as well as evaluate pertinent clinical data on therapies that target key immunologic mediators in severe asthma. Faculty also discuss methods to assess and improve medication adherence. The program concludes with the Wheel of Knowledge, an interactive gaming segment designed to reinforce topics addressed in the preceding didactic presentations.


Target Audience

The intended audience for this activity is family physicians, internists, and other health care professionals involved in the management of patients with asthma.


Learning Objectives

Upon completion of this educational activity, the participant may be better able to:

  • Describe common classifications of asthma phenotypes and their implications for therapy.
  • Describe the clinical consequences of poor adherence and improper inhaler use in patients with asthma.
  • Incorporate strategies for improving adherence and proper inhaler use in patients with asthma

Activity Chair

Michael S. Blaiss, MD
Executive Medical Director
American College of Allergy, Asthma, and Immunology
Physician (Allergy/Asthma)
Good Samaritan Health Clinic East Gwinnett
Norcross, GA
Clinical Professor of Pediatrics
Medical College of Georgia at Augusta University
Augusta, GA


Faculty

Nicola A. Hanania, MD, MS
Associate Professor, Medicine-Pulmonary
Director, Airways Clinical Research Center
Member, Vice Chair of Research Group
Baylor College of Medicine
Director, Asthma and COPD Clinic
Ben Taub Hospital
Houston, TX

Neil S. Skolnik, MD, FAAFP
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Abington, PA


Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Ronald A. Codario, Jr., MD


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

AMA/AAFP Equivalency:
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1

This enduring material is approved for 1 year from the date of original release, December 16, 2019, through December 15, 2020.


How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


MIPS Qualifying Activity:
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.
To meet the criteria for improvement activities in the Merit-Based Incentive Payment System (MIPS) of QPP, accredited CME providers need to implement activities that:

  • address a quality or safety gap that is supported by a needs assessment or problem analysis, or support the completion of such a needs assessment as part of the activity;
  • have specific, measurable aim(s) for improvement;
  • include interventions intended to result in improvement;
  • include data collection and analysis of performance data to assess the impact of the interventions; and
  • define meaningful clinician participation in their activity, describe the mechanism for identifying clinicians who meet the requirements, and provide participant completion information.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

Activity Chair and Faculty report the following relationship(s)

Michael S. Blaiss, MD
Consulting Fee: Sanofi/Regeneron

Nicola A. Hanania, MD, MS
Consulting Fee: AstraZeneca, Genentech, GlaxoSmithKline, Novartis, Regeneron, Sanofi Genzyme
Speakers Bureau: AstraZeneca
Contracted Research: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Sanofi Regeneron

Neil S. Skolnik, MD, FAAFP
Consulting Fee: AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Intarcia, Janssen, Lilly, Merck, Mylan, Sanofi, Teva
Speakers Bureau: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Lilly
Contracted Research: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Ronald A. Codario, Jr., MD
No relevant financial relationships to disclose. 

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at CME@VindicoCME.com